Dublin, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/gk23nq/molecular) has announced the addition of the "Molecular Diagnostic Testing for Infectious Diseases Global Market Size, Strategies and Forecasts 2016 to 2020 " report to their offering.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. Infectious disease testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- changing demographics
- emerging economies and global prosperity
- biotechnology advances in genetics
- pathogen evolution
- climate change
- globalization
- automation
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
This research makes you the expert in your organization.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Market Analysis by Disease
3. Industry Overview
4. Market Trends
5. Molecular Dx - Infectious Disease Recent Developments
6. Country Market Sizes - North America
7. Country Markets - Europe
8. Country Markets - Asia Pacific
9. Country Markets - Latin America, Africa & The Middle East
10. Global Market Summary
Companies Mentioned
- Abbott Laboratories
- Agendia
- Agilent/Dako
- Becton, Dickinson & Co.
- bioMérieux
- Cepheid
- Foundation Medicine
- Genomic Health
- Grifols
- Hologic
- Illumina
- Myriad Genetics
- Qiagen
- Roche Molecular Diagnostics
- Siemens Healthcare
- Signal Genetics LLC
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/gk23nq/molecular
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, In Vitro Diagnostics, Infectious Disease Testing, Molecular Diagnostics


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users 



